From energy to fatigue: DSM-Firmenich's soft Q3
30/10/25 -"DSM has fallen short of expectations, delivering organic revenue growth at 2%, while the consensus was expecting 50bps more. Despite this, the EBITDA adj. miss has been less significant, but it has ..."
Pages
64
Language
English
Published on
30/10/25
You may also be interested by these reports :
30/10/25
Clariant’s Q3 results remained soft on the back of industry-wide macroeconomic weakness. However, improved pricing and mix, along with cost-side ...
30/10/25
DSM has fallen short of expectations, delivering organic revenue growth at 2%, while the consensus was expecting 50bps more. Despite this, the EBITDA ...
30/10/25
3Q25 EBITDA 5% above consensus – FY25 guidance confirmed
29/10/25
BASF’s Q3 results were slightly above expectations, despite a weak macro backdrop – although divisional dynamics were mixed. Plus, good progress on ...